PL EN


Preferencje help
Widoczny [Schowaj] Abstrakt
Liczba wyników
Tytuł artykułu

The pair-wise linear classifier and the k-NN rule in application to ALS progression differentiation

Treść / Zawartość
Identyfikatory
Warianty tytułu
Języki publikacji
EN
Abstrakty
EN
The two kinds of classifier based on the k-NN rule, the standard and the parallel version, were used for recognition of severity of ALS disease. In case of the second classifier version, feature selection was done separately for each pair of classes. The error rate, estimated by the leave one out method, was used as a criterion as for determination the optimum values of k's as well as for feature selection. All features selected in this manner were used in the standard and in the parallel classifier based on k-NN rule. Furthermore, only for the verification purpose, the linear classifier was applied. For this kind of classifier the error rates were calculated by use the training set also as a testing one. The linear classifier was trained by the error correction algorithm with a modified stop condition. The data set concerned with the healthy subjects and patients with amyotrophic lateral sclerosis (ALS). The set of several biomarkers such as erythropoietin, matrix metalloproteinases and their tissue inhibitors measured in serum and cerebrospinal fluid (CSF) were treated as features. It was shown that CSF biomarkers were very sensitive for the ALS progress.
Rocznik
Tom
Strony
79--83
Opis fizyczny
Bibliogr. 12 poz., tab.
Twórcy
  • Bioinformatics Laboratory, Mossakowski Medical Research Center, Polish Academy of Sciences, 02-106 Warszawa, Pawińskiego 5
autor
autor
Bibliografia
  • [1] BROOKS B.R., MILLER R.G., SWASH M., MUNSAT T.L., El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis, Amyotrophic Lateral Sclerosis and other Motor Neuron Disorder, 2000, Vol. 1, pp. 293-299.
  • [2] CUDKOWICZ M., QURESHI M., SHEFNER J., Measures and Markers in Amyotrophic Lateral Sclerosis, NeuroRx, 2004, Vol. 1, No. 2, pp. 273-283.
  • [3] JANIK P., KWIECINSKI H., SOKOLOWSKA B., NIEBROJ-DOBOSZ I., Erythropoietin concentration in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis, Journal of Neural Transmission, 2010, Vol. 117, pp. 343–347.
  • [4] JÓŹWIK A., SERPICO S., ROLI F., A parallel network of modified 1-NN and k-NN classifiers -application to remote-sensing image classification, Pattern Recognition Letters, 1998, Vol. 19, pp. 57-62.
  • [5] JÓŹWIK A., SOKOŁOWSKA B., NIEBOJ-DOBOSZ I., JANIK P., KWIECIŃSKI H., Extraction of biomedical traits for patients with amyotrophic lateral sclerosis using parallel and hierarchical classifiers, International Journal of Biometrics, 2011, Vol. 3, No. 1, pp. 85-94.
  • [6] JÓŹWIK A., SOKOŁOWSKA B., NIEBROJ-DOBOSZ I., JANIK P., KWIECIŃSKI H., Pattern recognition approach to differentiation of disease severity in patients with amyotrophic lateral sclerosis, Journal of Medical Informatics & Technologies, 2008, Vol. 12, pp. 143-147.
  • [7] KUDO L.C., PARFENOVA L., VI N., LAU K., POMAKIAN J., VALDMANIS P., ROULEAU G.A., VINTERS H.V., WIEDAU-PAZOS M., KARSTEN S.L., Integrative gene-tissue microarray-based approach for identification of human disease biomarkers: Application to amyotrophic lateral sclerosis, Human Molecular Genetics, 2010, Vol. 19, No. 16, pp. 3233-3253.
  • [8] NIEBROJ-DOBOSZ I., JANIK P., SOKOŁOWSKA B., KWIECIŃSKI H., Matrix metalloproteinases and their tissue inhibitors in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis, European Journal of Neurology, 2010, Vol. 17, pp. 226–231.
  • [9] NILSSON N., Learning machines, McGraw-Hill, New York, 1965.
  • [10] SOKOŁOWSKA B., JOZWIK A., NIEBROJ-DOBOSZ I., JANIK P., KWIECIŃSKI H., Evaluation of matrix metalloproteinases in serum of patients with amyotrophic lateral sclerosis with pattern recognition methods, Journal of Physiology and Pharmacology, 2009, Vol. 60, Suppl. 5, pp. 117-120.
  • [11] SOKOŁOWSKA B., JOZWIK A., NIEBROJ-DOBOSZ I., JANIK P., KWIECIŃSKI H., Analysis of matrix metalloproteinases (MMPs) in cerebrospinal fluid of patients with amyotrophic lateral sclerosis (ALS), Journal of Medical Informatics & Technologies, 2009, Vol. 13, pp. 147-150.
  • [12] STRONG M.J., The basic aspects of therapeutics in amyotrophic lateral sclerosis, Pharmacology &Therapeutics, 2003, Vol. 98, pp. 379–414.
Typ dokumentu
Bibliografia
Identyfikator YADDA
bwmeta1.element.baztech-article-PWA4-0027-0009
JavaScript jest wyłączony w Twojej przeglądarce internetowej. Włącz go, a następnie odśwież stronę, aby móc w pełni z niej korzystać.